Securities Fraud

Rev. Father Emmanuel Lemelson and Lemelson Capital Mgmt., LLC v. Securities and Exchange Commission Shelburn, VT (August 1, 2023) – Whistleblower and activist i...

To read the full Opposition click here or view on Scribd below. "That is, the Commission promoted Ligand’s stock price in its Complaint, which was riddled with...

To read the full Motion For Summary Judgment click here or view on Scribd below with the statement of facts and exhibits. To say this enforcement action is unpr...

To read the full affidavit click here or view below on Scribd with the complete list of exhibits attached. In March 2020 Fr. Emmanuel Lemelson was held in conte...

On January 28, 2020, U.S. magistrate judge Donald L. Cabell, ruled in favor of Rev. Fr. Emmanuel Lemelson, denying the SEC request for a protective order and gr...

Lemelson Capital Management To Announce Fiscal 2019 Results For The Amvona Fund, LP On January 21, 2020 Watch! "This Is A Rigged Game" As Ligand Pharmaceuticals...

To read the full Opposition to The Securities and Exchange Commission's motion for protective order click here or view on Scribd below. For more background see...

Fr. Emmanuel Lemelson speaks out against alleged fraud and complicit regulators as Ligand shares continue to implode, heading towards new multi-year lows Shelbu...

Lemelson Capital Increases Short Position in Ligand Pharmaceuticals (NASDAQ: LGND), Calls on US Attorney to Investigate As Ligand shares implode, reaching new m...

...the company faces it biggest existential threat in what is likely to be a momentous impairment of its largest royalty generating asset, Promacta," Fr. Emmanu...

Ligand is only one market correction away from collapse which will leave investors and employees defenseless." Fr. Emmanuel Lemelson, July 13, 2018 Letter to Co...

Shares of Ligand Pharmaceuticals (NASDAQ: LGND) continued to plunge today, December 17, 2018, falling as much as 52 percent since September 30, 2018, and hittin...